ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "rituximab plus cyclophosphamide"
rituximab plus cyclophosphamide
Publikace
Předměty
Osoby
Publikace
Studium
publication
Rituximab versus cyklofosfamid v ANCA- sociované vaskulitidě.
2010 |
1. lékařská fakulta
publication
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
2015 |
1. lékařská fakulta
publication
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
2017 |
Publikace bez příslušnosti k fakultě
publication
Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
2019 |
Lékařská fakulta v Hradci Králové
publication
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
2011 |
1. lékařská fakulta
publication
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
2015 |
Publikace bez příslušnosti k fakultě
publication
Léčba starších pacientů s lymfomem plášťových buněk
2012 |
1. lékařská fakulta
publication
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma
2020 |
1. lékařská fakulta
publication
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2017 |
1. lékařská fakulta
publication
Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL
2021 |
1. lékařská fakulta
publication
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
2016 |
Lékařská fakulta v Hradci Králové
publication
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
2022 |
1. lékařská fakulta
publication
Combined Therapeutic Modality with Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Transplantation (ASCT) Leads to Excellent Response Rate and High Probability of Molecular Remission in Chronic Lymphocytic Leukemia (CLL) Patients
Publikace bez příslušnosti k fakultě
publication
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP
2020 |
1. lékařská fakulta, 2. lékařská fakulta, 3. lékařská fakulta
publication
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
2019 |
1. lékařská fakulta
publication
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
2021 |
1. lékařská fakulta
publication
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
2019 |
1. lékařská fakulta
publication
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
2021 |
Lékařská fakulta v Hradci Králové, Ústřední knihovna
publication
Antibody-Negative Autoimmune Encephalitis: A Single-Center Retrospective Analysis
2023 |
Ústřední knihovna, 2. léka řská fakulta